Locations:
February 8, 2021/Cancer/Patient Support

New NCCN Guidelines Focus on Key Aspects of Survivorship

Patient resources promote healthy living, management of late and long-term side effects

Cancer survivor

Two new guidelines from the National Comprehensive Cancer Network (NCCN) offer jargon-free information that clinicians can use to help counsel and educate patients about what comes after an initial cancer diagnosis and therapy for the disease.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Part of NCCN’s “Survivorship” series, the publications address late and long-term effects of cancer and cancer treatment, and factors that are key to healthy living. Designed for patients with adult-onset cancer, they are applicable whether an individual’s cancer treatment is ongoing or has been paused, stopped, or completed. 

“Primary care physicians can’t be experts in all of the areas covered in the NCCN physician guidelines, and these guidelines can help them understand what sort of issues survivors they see may be facing and provide appropriate resources or referrals,” says Halle C.F. Moore, MD, Director of the Breast Cancer Program at Cleveland Clinic Cancer Center. “The patient guidelines are ideal for use at the time of a comprehensive survivorship assessment, during which treatment, symptoms or delayed effects may be discussed.”

Broad and multidisciplinary consensus

Endorsed by Good Days, the American Lung Association, Be the Match, the Cancer Hope Network, the Save Your Skin Foundation, and The Leukemia & Lymphoma Society, the guidelines were developed by a panel of experts. Among them are oncologists and specialists in bone marrow transplantation, urology, cardiology and psychology, as well as a primary care physician, nutrition scientist, nurse, epidemiologist and a sociologist.

“The group is a pretty broad and multidisciplinary group, and it includes at least one cancer survivor,” says Dr. Moore, who represents the Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center and Cleveland Clinic on the panel. “We come together to update the guidelines every year, based on a thorough review of the current literature and expert opinion. That process informs development of recommendations based on consensus grading.”

Advertisement

Screening and cardiovascular risk updates

The new publication on cancer-related late and long-term effects covers topics such as lymphedema, cognitive dysfunction, sexual dysfunction, fatigue, sleep, pain and distress and mental health. The two most noteworthy additions to it in 2020, according to Dr. Moore, are an expanded section on cardiovascular disease risk and a significant update related to screening for subsequent primary malignancies.

“We know that cancer survivors are at higher risk for cardiovascular disease for a variety of reasons, which may be related to their treatment or to shared risk factors for cancer and cardiovascular disease — smoking, age and obesity, among others,” she says. “The guidelines provide tools that clinicians can use to assess traditional and cancer treatment-related risk factors when guiding patients and recommendations for counseling to help mitigate those risks.”

The healthy living guideline reviews physical activity, food and supplements, weight and metabolism, and prevention of infections. Both publications include an appendix with resources and a glossary of key terms, as well as listings of NCCN cancer centers. “Survivorship Care for Healthy Living” and “Survivorship Care for Cancer-Related Late and Long-Term Effects” are available for free to view and print at NNCN.org/patients or via the NCCN Patient Guides for Cancer App.

“Good care for cancer survivors begins at diagnosis and can improve a patient’s health, wellness and quality of life,” says Dr. Moore. “These NCCN publications can further that goal by facilitating coordination of care between primary care physicians, oncologists and other clinicians, and providing evidence-based guidance on health maintenance, screening for and evaluation of consequences of cancer and cancer treatment.”

Advertisement

Related Articles

Dr. Dedousis
November 2, 2026/Cancer/Podcast

Expanding Germline Genetic Testing in Oncology (Podcast)

Are we missing patients?

Dr. Hanlee Chung
October 29, 2026/Cancer/Podcast

Redefining Resectability in Advanced Rectal Cancer (Podcast)

Expanding treatment options for patients with advanced and recurrent rectal cancer

Patient and healthcare providers
October 28, 2026/Cancer/Patient Support

Desire for Preventative Screening is Strong Among People Experiencing Homelessness

Study analyzes creative approaches to support people facing housing insecurity

AI tech
October 26, 2026/Cancer/Innovations

AI Task Force Develops Unified Strategy to Integrate Tech Innovations

Evaluating AI initiatives and their impact on operations and care delivery

DNA test
October 23, 2026/Cancer/News & Insight

Early Genetic Testing Linked to Bilateral Mastectomy in Young BRCA Carriers with Breast Cancer

Study reinforces the importance of genetic testing prior to local therapy decisions

Dr. Arun Singh
October 21, 2026/Cancer

Preserving Vision in Uveal Melanoma (Podcast)

Understanding expanding treatment options and potential advances

Patient and doctor
October 9, 2026/Cancer/News & Insight

First Radioligand Therapy Approved for Metastatic Hormone-Sensitive Prostate Cancer

Adding 177Lu-PSMA-617 to ADT plus an ARPI cut the risk of radiographic progression or mortality by 28%

Woman running
October 7, 2026/Cancer/Patient Support

Pilot Project Aids Cancer Survivors in Achieving Healthy Weight and Reducing Recurrent Risk

New program will help patients improve fitness and manage weight after cancer treatment

Ad